GLU-27 variant of β2-adrenergic receptor polymorphisms is an independent risk factor for coronary atherosclerotic disease

Atherosclerosis

Volumn 194, Issue 2, 2007, Pages

  Barbato, Emanuele ^a   Berger, Alexandre ^a   Delrue, Leen ^a   Van Durme, Frederik ^a   Manoharan, Ganesh ^a   Boussy, Tim ^a   Heyndrickx, Guy R ^a   De Bruyne, Bernard ^a   Ciampi, Quirino ^b   Vanderheyden, Marc ^a   Wijns, William ^a   Bartunek, Jozef ^a  

^a CARDIOVASCULAR CENTER   (Belgium)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

2 Adrenergic receptor; Atherosclerosis; Coronary; Polymorphism; Risk factor

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; GLYCINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOLEUCINE; THREONINE;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BETA ADRENERGIC STIMULATION; BLOOD DONOR; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; FEMALE; FOLLOW UP; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HEART CATHETERIZATION; HEART MUSCLE REVASCULARIZATION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT REFERRAL; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SILENT MYOCARDIAL ISCHEMIA;

AGED; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2;

EID: 34848830781     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.09.029     Document Type: Article

References (24)

1. Barbato E., Piscione F., Bartunek J., et al. Role of beta 2 adrenergic receptors in human atherosclerotic coronary arteries. Circulation 111 3 (2005) 288-294
2. Green S.A., Turki J., Innis M., and Ligget S.B. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33 47 (1994) 14368
3. Rosmond R., Ukkola O., Chagnon M., Bouchard C., and Bjorntorp P. Polymorphisms of the β2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men. J Intern Med 248 (2000) 239-244
4. Large V., Hellstrom L., Reynisdottir S., et al. Human beta-2 adrenoceptos gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 100 (1997) 3005-3013
5. Masuo K., Katsuya T., Fu Y., et al. Beta 2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals. Am J Hypertens 18 7 (2005) 1009-1014
6. Macho-Azcarate T., Marti A., Gonzalez A., Martinez J.A., and Ibanez J. Gln27Glu polymorphism in the beta 2 adrenergic receptor gene and lipid metabolism during exercise in obese women. Int J Obes Relat Metab Disord 26 (2002) 1434-1441
7. Bray M.S., Krushkal J., Li L., et al. Positional genomic analysis identifies the β2-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 101 (2000) 2877-2882
8. Iaccarino G., Lanni F., Cipolletta E., et al. The Glu27 allele of the β2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertension. J Hypertens 22 (2004) 1-6
9. Yamada Y., Izawa H., Ichihara S., et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 347 (2002) 1916-1923
10. Herrmann S.M., Nicaud V., Tiret L., et al. Polymorphisms of the β2-adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies. J Hypertens 20 (2002) 229-235
11. Heckbert S.R., Hindorff L.A., Edwards K.L., et al. β2-Adrenergic receptor polymorphisms and risk of incident cardiovascular events in the elderly. Circulation 107 (2003) 2021-2024
12. Zee R.Y., Cook N.R., Reynolds R., Cheng S., and Ridker P.M. Haplotype analysis of the β2 adrenergic receptor gene and risk of myocardial infarction in humans. Genetics 169 (2005) 1583-1587
13. Zee R.Y., Cook N.R., Cheng S., et al. Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis. J Thromb Haemost 4 2 (2006) 341-348
14. Guidelines, Subcommittee. World Health Organization-International Society of Hypertension Guidelines for the Management of, Hypertension. J Hypertens 17 (1999) 151-183
15. World Health Organization Study Group. Diabetes mellitus. WHO Tech Rep Ser 1985; 727:1-104.
16. Vatner S.F., Hintze T.H., and Macho P. Regulation of large coronary arteries by beta-adrenergic mechanisms in the conscious dog. Circ Res 51 1 (1982) 56-66
17. Hodgson J.M., Cohen M.D., Szentpetery S., and Thames M.D. Effects of regional alpha- and beta-blockade on resting and hyperemic coronary blood flow in conscious, unstressed humans. Circulation 79 4 (1989) 797-809
18. 1-adrenergic stimulation in vitro. J Cardiovasc Pharmacol 25 1 (1995) 134-141
19. Cockcroft J.R., Gazis A.G., Cross D.J., et al. Beta2-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 36 (2000) 371-375
20. Dishy V., Sofowora G.G., Xie H.-G., et al. The effect of common polymorphisms of the beta 2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 345 (2001) 1030-1035
21. Kaplan J.R., Manuck S.B., Clarkson T.B., et al. Social stress and atherosclerosis in normocholesterolemic monkeys. Science 220 (1983) 733-735
22. Kaplan J.R., Manuck S.B., Adams M.R., Weingand K.W., and Clarkson T.B. Inhibition of coronary atherosclerosis by propranolol in behaviourally predisposed monkeys fed an atherogenic diet. Circulation 76 (1987) 1364-1372
23. Hedblad B., Wikstrand J., Janzon L., Wedel H., and Berglund G. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: main results from the β-blocker cholesterol-lowering asymptomatic plaque study (BCAPS). Circulation 103 (2001) 1721-1726
24. Iaccarino G., Trimarco V., Lanni F., et al. Beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene. Pharmacogenomics 5 5 (2005) 292-297